Gene editing

Wyss Institute and Cytosurge collaborate on CRISPR tech

The Wyss Institute at Harvard is joining forces with Swiss Biotech Cytosurge in a bid to improve CRISPR-based multiplexed gene editing with a single-cell...

Longevity2020: Day 5 Recap

On Friday, the Longevity2020 online conference drew to a close, and the final day explored what people can be doing today to address their...

Longevity2020: Day 2 recap

Yesterday at Longevity2020 was all about rejuvenation therapies, bringing together some of the world’s leading luminaries in the fight against aging. Things kicked off with...

BioViva to spin out its R&D and bioinformatics

CEO in the front-line: Liz Parrish talks gene therapy, patient data and funding. From academics and entrepreneurs to engineers and technologists, the battle against aging...

Reprogram, rejuvenate, rewind: spinout

Soaking up Longevity - a Stanford University team has rejuvenated aging human cells with a novel protein "bath" and formed a spinout. Researchers at Stanford...

Better, faster, stronger CRISPR

Cytosurge claims to be able to make CRISPR “better and faster than anybody else on single cell level” - seeking investment to evolve world’s smallest syringe...

Fishing for regenerative therapies

Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory. Nestled on the picturesque coastline of Maine, USA, the...

Human CRISPR trial heralds Longevity success

Trial finds not only that gene-edited immune cells are safe, but that they survive and thrive after being placed into patients suffering from advanced...

Rejuvenate Bio teaches old dogs new tricks

A combination gene therapy developed by the Wyss Institute and Harvard Medical School is set to treat several age-related conditions in dogs, extending their...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

UK Gov releases human germline editing brief

Human Germline Genome Engineering is a highly controversial area – altering genes so that changes are passed on to all descendants.  Just because we...

Ageotype: Four new types of biomarker

You’ve obviously heard of stereotype. But how about an ageotype? Scientists have identified at least four types of aging, which could explain why we...

Healios bets on natural born killers

Healios is turning to natural killer cells (NK) to develop a range of new treatments which target solid tumours. Regenerative medicine innovator Healios KK has...

CRISPR in-body gene revolution gets underway

It has been an ethical minefield, but a scientific revolution. Could CRISPR in-body now be the next step in health span and lifespan therapies? Crispr...

Healios to fast-track pluripotent stem cell therapy

Healios K.K. to bring its novel regenerative pluripotent stem cell treatments to market through accelerated Japanese approvals process. Stem cell pioneers Healios KK will use...

Primetime for more powerful CRISPR tech

Researchers have developed a novel and more powerful form of CRISPR that offers the possibility to correct most disease-causing genetic variations in DNA  –...

Machine learning and fast track gene therapy

Following latest research at Harvard's Wyss Institute, a machine learning tool could be key to the future of gene therapy delivery. Gene therapies have long...

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Genetic discoveries: Implications for Longevity

New genetic discoveries suggest that components of the extracellular matrix might represent a link between immune defence and Longevity: Present and future directions. Even though...

Gene test predicts sudden cardiac death

Identification of rare DNA variants might flag up individuals at high risk of cardiac death before any symptoms appear. Globally, sudden and unexpected cardiac death...

Latest articles

Selfie biomarkers: AI and insurtech implications for Longevity

AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...

Low levels of stress hormone contributes to aging

When it comes to the stress hormone cortisol, balance is everything, according to a new study in Germany.  There have been plenty of studies that...

Rejuvenation Roadmap charts life extension progress

We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress. Lifespan.io is a US-based non-profit organisation that seeks to...

Longevity therapies delivered through skin is a topical issue

Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème. Therapeutic substances like arnica, turmeric and witch hazel have been...